The Cytek BioSciences Inc (CTKB) Stock expansion path ahead

Stephens raised the price target for the Cytek BioSciences Inc (NASDAQ:CTKB) stock to “an Overweight”. The rating was released on December 14, 2023, according to finviz. The research report from Piper Sandler has resumed the stock to Overweight, with a price target set at $20. The latest trade, Performances and Moving Averages give us the […]

Is it possible to sustain this rally? Cytek BioSciences Inc (CTKB) Stock

Stephens raised the price target for the Cytek BioSciences Inc (NASDAQ:CTKB) stock to “an Overweight”. The rating was released on December 14, 2023, according to finviz. The research report from Piper Sandler has resumed the stock to Overweight, with a price target set at $20. The latest trade, Performances and Moving Averages give us the […]